Treatment of multidrug-resistant tuberculosis in a remote, conflict-affected area of the Democratic Republic of Congo.

Hdl Handle:
http://hdl.handle.net/10144/271998
Title:
Treatment of multidrug-resistant tuberculosis in a remote, conflict-affected area of the Democratic Republic of Congo.
Authors:
Shanks, L; Masumbuko, E W; Ngoy, N M; Maneno, M; Bartlett, S; Thi, S S; Shah, T
Journal:
International Journal of Tuberculosis and Lung Disease
Abstract:
The Democratic Republic of Congo is a high-burden country for multidrug-resistant tuberculosis. Médecins Sans Frontières has supported the Ministry of Health in the conflict-affected region of Shabunda since 1997. In 2006, three patients were diagnosed with drug-resistant TB (DR-TB) and had no options for further treatment. An innovative model was developed to treat these patients despite the remote setting. Key innovations were the devolving of responsibility for treatment to non-TB clinicians remotely supported by a TB specialist, use of simplified monitoring protocols, and a strong focus on addressing stigma to support adherence. Treatment was successfully completed after a median of 24 months. This pilot programme demonstrates that successful treatment for DR-TB is possible on a small scale in remote settings.
Affiliation:
Médecins Sans Frontières, Amsterdam, The Netherlands; Medecins
Issue Date:
4-May-2012
URI:
http://hdl.handle.net/10144/271998
DOI:
10.5588/ijtld.11.0240
PubMed ID:
22565108
Language:
en
ISSN:
1815-7920
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorShanks, Len_GB
dc.contributor.authorMasumbuko, E Wen_GB
dc.contributor.authorNgoy, N Men_GB
dc.contributor.authorManeno, Men_GB
dc.contributor.authorBartlett, Sen_GB
dc.contributor.authorThi, S Sen_GB
dc.contributor.authorShah, Ten_GB
dc.date.accessioned2013-03-13T12:04:55Z-
dc.date.available2013-03-13T12:04:55Z-
dc.date.issued2012-05-04-
dc.identifier.citationJ Tuberc. Lung Dis;16 (8):1066-8.en_GB
dc.identifier.issn1815-7920-
dc.identifier.pmid22565108-
dc.identifier.doi10.5588/ijtld.11.0240-
dc.identifier.urihttp://hdl.handle.net/10144/271998-
dc.description.abstractThe Democratic Republic of Congo is a high-burden country for multidrug-resistant tuberculosis. Médecins Sans Frontières has supported the Ministry of Health in the conflict-affected region of Shabunda since 1997. In 2006, three patients were diagnosed with drug-resistant TB (DR-TB) and had no options for further treatment. An innovative model was developed to treat these patients despite the remote setting. Key innovations were the devolving of responsibility for treatment to non-TB clinicians remotely supported by a TB specialist, use of simplified monitoring protocols, and a strong focus on addressing stigma to support adherence. Treatment was successfully completed after a median of 24 months. This pilot programme demonstrates that successful treatment for DR-TB is possible on a small scale in remote settings.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to The International Journal of Tuberculosis and Lung Disease : the official journal of the International Union Against Tuberculosis and Lung Diseaseen_GB
dc.subjectTuberculosisen_GB
dc.titleTreatment of multidrug-resistant tuberculosis in a remote, conflict-affected area of the Democratic Republic of Congo.en
dc.contributor.departmentMédecins Sans Frontières, Amsterdam, The Netherlands; Medecinsen_GB
dc.identifier.journalInternational Journal of Tuberculosis and Lung Diseaseen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.